Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Gross Profit: 2021-2024

Historic Gross Profit for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $18.7 million.

  • Biofrontera's Gross Profit rose 19.54% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 2.39%. This contributed to the annual value of $18.7 million for FY2024, which is 12.55% up from last year.
  • According to the latest figures from FY2024, Biofrontera's Gross Profit is $18.7 million, which was up 12.55% from $16.6 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Gross Profit registered a high of $23.6 million during FY2021, and its lowest value of $10.8 million during FY2022.
  • Its 3-year average for Gross Profit is $15.4 million, with a median of $16.6 million in 2023.
  • In the last 5 years, Biofrontera's Gross Profit crashed by 54.31% in 2022 and then skyrocketed by 54.33% in 2023.
  • Over the past 4 years, Biofrontera's Gross Profit (Yearly) stood at $23.6 million in 2021, then tumbled by 54.31% to $10.8 million in 2022, then skyrocketed by 54.33% to $16.6 million in 2023, then grew by 12.55% to $18.7 million in 2024.